ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,626.02
0.54%
US Tech 100
18,986.40
0.30%
Dow Jones
41,393.78
0.72%
Brent Oil
71.825
0.00%
Bitcoin
60,107.63
-0.78%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Longboard Pharmaceuticals Inc (LBPH) Quote

Longboard Pharmaceuticals Inc

Longboard Pharmaceuticals Inc (LBPH)

NASDAQ
34.32
1.05
(3.16%)
Closed September 14 4:00PM
Delayed by 15 minutes
34.9977
0.6777
(1.97%)
After Hours: 7:10PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
34.9977
Bid
31.74
Ask
35.26
Volume
159,217
33.20 Day's Range 34.80
2.70 52 Week Range 40.48
Market Cap
1.361B
Previous Close
33.27
Open
33.29
Last Trade
2
@
34.895
Last Trade Time
Financial Volume
$ 5,434,684
VWAP
34.1338
Average Volume (3m)
495,099
Shares Outstanding
38,899,521
Dividend Yield
-
PE Ratio
-24.55
Earnings Per Share (EPS)
-1.4
Revenue
-
Net Profit
-54.42M

About Longboard Pharmaceuticals Inc

Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659. Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.longboardpharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Longboard Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LBPH. The last closing price for Longboard Pharmaceuticals was $33.27. Over the last year, Longboard Pharmaceuticals shares have traded in a share price range of $ 2.70 to $ 40.48.

Longboard Pharmaceuticals currently has 38,899,521 shares outstanding. The market capitalization of Longboard Pharmaceuticals is $1.29 billion. Longboard Pharmaceuticals has a price to earnings ratio (PE ratio) of -24.55.

Ask ADVFN Intelligence (AI)

LBPH Latest News

More News

Longboard Pharmaceuticals Announces Positive Interim Analysis Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs)

Bexicaserin achieved an overall median seizure reduction of 57.7% in countable motor seizures over an approximate 9-month treatment period Favorable safety and tolerability results continue to...

September 08 2024
Business Wire

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the...

September 06 2024
Business Wire

Longboard Pharmaceuticals to Participate in Four Upcoming Investor Conferences in September

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that...

August 28 2024
Business Wire

Longboard Pharmaceuticals to Present Late-Breaking and Encore Data at the 15th European Epilepsy Congress

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it...

August 26 2024
Business Wire

Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on September 16, 2024

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it...

August 26 2024
Business Wire

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the...

August 02 2024
Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

August 01 2024
Edgar (US Regulatory)

Form 8-K - Current report

August 01 2024
Edgar (US Regulatory)

Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Bexicaserin (LP352) received Breakthrough Therapy designation (BTD) for the treatment of seizures associated with Developmental and Epileptic Encephalopathies (DEEs) for patients two years of...

August 01 2024
Business Wire

Longboard Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host Corporate Update Call on August 1

Conference call to discuss corporate updates, including Phase 1 single ascending dose (SAD) topline data for LP659 in healthy volunteers Conference call and webcast to be held August 1 at 4:30pm...

July 29 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0523-0.14921540656235.0538.249932.7855646935.16508601CS
414.947774.552119700720.0540.4819.659763679233.82063144CS
1214.647771.978869778920.3540.4815.6449509927.83622583CS
2628.8277467.2236628856.1740.483.661314424.84548902CS
5224.1777223.45378927910.8240.482.723217822.59133554CS
15618.9977118.7356251640.482.720797922.12355895CS
26000036.98000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NOVVUNova Vision Acquisition Corporation
$ 41.00
(207.35%)
17.4k
NOVVNova Vision Acquisition Corporation
$ 37.0001
(200.08%)
202.75k
SMXSMX Security Matters Public Company
$ 5.85
(138.78%)
49.72M
OMICSingular Genomics Systems Inc
$ 12.38
(119.12%)
2.72M
TILInstill Bio Inc
$ 84.75
(82.41%)
3.76M
GSIWGarden Stage Ltd
$ 2.9693
(-75.66%)
4.24M
UPCUniverse Pharmaceuticals Inc
$ 0.55
(-67.07%)
30.45M
VMARVision Marine Technologies Inc
$ 0.77
(-48.67%)
34.54M
PRLDPrelude Therapeutics Inc
$ 2.775
(-42.55%)
2.49M
CNEYCN Energy Group Inc
$ 0.4335
(-37.17%)
5.06M
NVDANVIDIA Corporation
$ 119.10
(-0.03%)
225.83M
XXII22nd Century Group Inc
$ 0.3447
(28.00%)
168.56M
IMRXImmuneering Corporation
$ 2.02
(41.26%)
131.85M
SQQQProShares UltraPro Short QQQ
$ 8.17
(-1.33%)
122.46M
MULNMullen Automotive Inc
$ 0.1328
(-20.48%)
119.52M

LBPH Discussion

View Posts
FALCON1 FALCON1 2 months ago
https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri
https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation
👍️0
TechandBio TechandBio 2 months ago
MY best performing Bio this year! Surfs up Vertical debit spreads from $5.00 are up over 1430% wish i went heavier keep an eye on ICCM

$LBPH
👍️0
da_stock_analyst da_stock_analyst 8 months ago
#LBPH 🔥 short squeeze might push this way higher! Nice set up!
👍️0
Backstabbed Backstabbed 8 months ago
Insane … grats all
👍️0
conix conix 8 months ago
LOTTO Ticket for 2024: Curative Biotechnology $CUBT @ $0.02 is a biotech with some very promising technology in the treatment of Age-Related Macular Degeneration (AMD). Metformin, a widely used diabetes drug, has been proven to have positive effects on patients with AMD. CUBT has a patented formulation for the direct delivery of metformin to the eye in the form of eye drops. The National Institutes of Health (NIH) will be funding a clinical trial on humans in 2024 in collaboration with the company. There has been a number of delays in the start of the trials, hence the low price, but the price has been firming up this past month. Although difficult to predict when these announcements happen, at these prices, CUBT is worth buying a small position (you can define "small") to make certain you are following the news and the price reaction so you can average up on your original position. Check the CUBT website out to see more info on the trials and the company's other drugs in the pipeline. Target Price by end of First Quarter (assuming clinical trial announcement)--$0.15).

SOURCE: https://www.reddit.com/r/pennystocks/comments/18uvm1j/trading_ideas_for_january_sing_migi_cubtmentioned/

It should go without saying, BUT some may need to read it...the above is someone's opinion. Nice to see anyways.
👍️0
conix conix 8 months ago
Congrats on being a quick thinker. Per-market buying can be risky, but does pan out.
👍️0
TheFinalCD TheFinalCD 8 months ago
The company has 9.5 months of cash left based on quarterly cash burn of -$13.28M and estimated current cash of $42.0M.
https://dilutiontracker.com/app/search/LBPH?a=dbb88c
👍️0
Stockexpertpro Stockexpertpro 8 months ago
AVTX Data Due on Watch here after 1 for 240 RS micro Float
👍️0
Laster Laster 8 months ago
Grabbed some at 8am immediately following news.
Looking good moving into open.
Sold half on double. Riding rest free.
What a way to start 2024!
👍️0
Monksdream Monksdream 8 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
tw0122 tw0122 8 months ago
An epileptic profit nice…
👍️0
cityimport cityimport 8 months ago
My First Almost 200% Profit (Within One Hour) In 2024 ... :)))))))))))))

In @ 6.25
Out @ 17.95

LBPH
👍️0

Your Recent History

NASDAQ
LBPH
Longboard Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved